Back to today’s briefing

Story perspectives

Breakthrough Drug Baxdrostat Promises Hope for Resistant Hypertension

8/30/2025

24 3

Summary

Story summary

Baxdrostat, a new blood pressure drug, effectively reduces systolic blood pressure by approximately 10 mmHg in one month.
It targets aldosterone production and represents the first new treatment for resistant hypertension in 20 years.
Regulatory approval for baxdrostat is anticipated soon, emphasizing its potential for managing challenging hypertension cases.

1 of 1

Story summary

Baxdrostat, a new blood pressure drug, effectively reduces systolic blood pressure by approximately 10 mmHg in one month.
It targets aldosterone production and represents the first new treatment for resistant hypertension in 20 years.
Regulatory approval for baxdrostat is anticipated soon, emphasizing its potential for managing challenging hypertension cases.